Published in Hypertension on December 12, 2005
Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med (2007) 3.48
Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res (2010) 3.16
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res (2012) 3.02
Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension (2008) 2.09
AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats. Am J Hypertens (2013) 1.65
Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol (2014) 1.64
Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. Antioxid Redox Signal (2014) 1.23
NADPH oxidases in vascular pathology. Antioxid Redox Signal (2013) 1.17
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res (2012) 1.14
Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol (2010) 1.13
NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol (2011) 1.08
Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension. Antioxid Redox Signal (2013) 1.04
High-salt diet and hypertension: focus on the renin-angiotensin system. Kidney Blood Press Res (2010) 1.04
Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. Hypertension (2008) 1.01
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol (2008) 1.01
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. Int J Hypertens (2011) 0.96
Differential roles of NADPH oxidases in vascular physiology and pathophysiology. Front Biosci (Schol Ed) (2012) 0.95
Targeting endothelial dysfunction in vascular complications associated with diabetes. Int J Vasc Med (2011) 0.89
Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II. Hypertension (2012) 0.85
Bone marrow transplantation improves endothelial function in hypertensive Dahl salt-sensitive rats. J Am Soc Hypertens (2012) 0.85
Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB. Cardiovasc Diabetol (2015) 0.85
NOX enzymes and diabetic complications. Semin Immunopathol (2008) 0.83
Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence? Biomed Res Int (2014) 0.82
The salted artery and angiotensin II signaling: a deadly duo in arterial disease. J Hypertens (2009) 0.80
Prevention of diabetes in hypertensive patients: results and implications from the VALUE trial. Vasc Health Risk Manag (2009) 0.79
Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension. Hypertension (2015) 0.76
Na/K-ATPase Signaling and Salt Sensitivity: The Role of Oxidative Stress. Antioxidants (Basel) (2017) 0.75
Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61
Retracted Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2002) 2.56
Surgical menopause increases salt sensitivity of blood pressure. Hypertension (2006) 2.38
NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol (2003) 2.30
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res (2002) 2.27
Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension (2008) 2.09
Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res (2003) 1.95
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res (2010) 1.91
Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens (2014) 1.83
Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood) (2006) 1.73
In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice. Kidney Int (2012) 1.67
Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation (2003) 1.59
Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med (2011) 1.56
Sodium challenge does not support an acute gastrointestinal-renal natriuretic signaling axis in humans. Kidney Int (2012) 1.46
NOX and inflammation in the vascular adventitia. Free Radic Biol Med (2009) 1.37
Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med (2008) 1.33
Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest (2008) 1.33
The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol (2002) 1.31
Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol (2004) 1.30
Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med (2011) 1.27
Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension (2008) 1.26
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? Cardiovasc Res (2007) 1.26
Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation (2006) 1.20
Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol (2006) 1.15
Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J (2006) 1.14
Depolarization of the macula densa induces superoxide production via NAD(P)H oxidase. Am J Physiol Renal Physiol (2007) 1.13
Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol (2005) 1.13
Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol (2004) 1.13
Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int (2005) 1.13
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension (2003) 1.12
NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells. J Physiol (2006) 1.11
Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2010) 1.10
Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension (2003) 1.07
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens (2010) 1.06
Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ Res (2004) 1.05
Body mass index and hypertension hemodynamic subtypes in the adult US population. Arch Intern Med (2009) 1.04
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol (2007) 1.04
Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am J Physiol Heart Circ Physiol (2006) 1.03
Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Hypertension (2004) 1.02
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol (2008) 1.01
GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta. Arterioscler Thromb Vasc Biol (2005) 1.01
Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol (2009) 1.00
Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens Rep (2007) 0.98
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS. Cell Mol Life Sci (2012) 0.96
The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol (2004) 0.96
HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arterioscler Thromb Vasc Biol (2009) 0.96
Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler Thromb Vasc Biol (2012) 0.96
Environmental tobacco smoke furthers progression of diabetic nephropathy. Am J Med Sci (2011) 0.96
The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls. Antioxid Redox Signal (2013) 0.96
Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study. J Am Soc Hypertens (2010) 0.95
Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am J Physiol Renal Physiol (2008) 0.95
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol (2010) 0.95
Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox). Circulation (2002) 0.94
Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev (2011) 0.94
Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress. Hypertension (2010) 0.94
Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens (2006) 0.94
Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens (2005) 0.94
Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis. Curr Hypertens Rep (2005) 0.93
Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens (2010) 0.93
Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl (2006) 0.93
Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension. Hypertension (2009) 0.93
Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens (2008) 0.92
Nicotine augments glomerular injury in a rat model of acute nephritis. Am J Nephrol (2008) 0.92
Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinase. Antioxid Redox Signal (2011) 0.92
Nitric oxide, angiotensin II, and hypertension. Semin Nephrol (2004) 0.92
Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens (2005) 0.91
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am J Physiol Heart Circ Physiol (2009) 0.91
Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest (2015) 0.91
Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc Res (2012) 0.90
Distinct hydrogen peroxide-induced constriction in multiple mouse arteries: potential influence of vascular polarization. Pharmacol Rep (2008) 0.90
Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension. Hypertension (2005) 0.90
The adventitia: the outs and ins of vascular disease. Cardiovasc Res (2007) 0.90
Major and minor electrocardiographic abnormalities and their association with underlying cardiovascular disease and risk factors in Hispanics/Latinos (from the Hispanic Community Health Study/Study of Latinos). Am J Cardiol (2013) 0.90
GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension (2003) 0.89
Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci (2013) 0.89
Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor. Am J Physiol Renal Physiol (2012) 0.88
Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr (2004) 0.88
The angiotensin II type 2 receptor: what is its clinical significance? Curr Hypertens Rep (2008) 0.87
Dissociation between metabolic and vascular insulin resistance in aging. Am J Physiol Heart Circ Physiol (2007) 0.86
Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens (2004) 0.86
Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep (2005) 0.86
Comparison of H2O2-induced vasoconstriction in the abdominal aorta and mesenteric artery of the mouse. Vascul Pharmacol (2007) 0.86
Role of c-Jun N-terminal kinase in the regulation of vascular tone. J Cardiovasc Pharmacol Ther (2010) 0.86
Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans. Hypertension (2006) 0.86
Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II. Hypertension (2012) 0.85
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension. J Am Soc Hypertens (2011) 0.85
Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice. Acta Neuropathol Commun (2014) 0.85
Cross-talk between nitric oxide and endothelium-derived hyperpolarizing factor: synergistic interaction? J Hypertens (2003) 0.85
Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Am J Physiol Heart Circ Physiol (2013) 0.85